Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90087709
Filing Date:08/02/2020
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Neurorx, Inc.
*MAILING ADDRESS
913 North Market Street, Suite 200
*CITY
Wilmington
*STATE
(Required for U.S. applicants)
Delaware
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19801
PHONE
202-340-1352
*EMAIL ADDRESS
XXXX
WEBSITE ADDRESS
www.neurorxpharma.com
LEGAL ENTITY INFORMATION
*TYPE
CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary,
genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and
disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
*FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
CORRESPONDENCE INFORMATION
NAME
Neurorx, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
jjavitt@neurorxpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
bdelbuono@neurorxpharma.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Plus
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
225
*TOTAL FEES DUE
225
*TOTAL FEES PAID
225
SIGNATURE INFORMATION
* SIGNATURE
//Jonathan C Javitt MD MPH//
* SIGNATORY'S NAME
Jonathan C. Javitt MD MPH
* SIGNATORY'S POSITION
Chief Executive Officer
SIGNATORY'S PHONE NUMBER
202-340-1352
* DATE SIGNED
08/02/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90087709
Filing Date:08/02/2020
To the Commissioner for Trademarks:
MARK: Samivir (Standard Characters, see mark)
The literal element of the mark consists of Samivir. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Neurorx, Inc., a corporation of Delaware, having an address of
913 North Market Street, Suite 200
Wilmington, Delaware 19801
United States
202-340-1352(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual
dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders;
Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For informational purposes only, applicant's website address is: www.neurorxpharma.com
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: //Jonathan C Javitt MD MPH// Date: 08/02/2020
Signatory's Name: Jonathan C. Javitt MD MPH
Signatory's Position: Chief Executive Officer
Signatory's Phone Number: 202-340-1352
Payment Sale Number: 90087709
Payment Accounting Date: 08/03/2020
Serial Number: 90087709
Internet Transmission Date: Sun Aug 02 00:43:25 ET 2020
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XX-2020080200432519
8345-90087709-7405f7a2f3fc295db0a0b2f609
82cc65aed762c85ef25f564a86d369c6b73fe-CC
-43239095-20200802002905108196